Connection

GRACE KIM to Immunosuppressive Agents

This is a "connection" page, showing publications GRACE KIM has written about Immunosuppressive Agents.
Connection Strength

0.954
  1. Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease. Arthritis Rheumatol. 2020 02; 72(2):316-325.
    View in: PubMed
    Score: 0.470
  2. Early Radiographic Progression of Scleroderma: Lung Disease Predicts Long-term Mortality. Chest. 2022 05; 161(5):1310-1319.
    View in: PubMed
    Score: 0.134
  3. Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II. Ann Am Thorac Soc. 2018 11; 15(11):1286-1295.
    View in: PubMed
    Score: 0.108
  4. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016 09; 4(9):708-719.
    View in: PubMed
    Score: 0.093
  5. Impact of quantitative radiological features of interstitial lung disease on immunomodulatory treatment response in three autoimmune interstitial lung disease cohorts. Thorax. 2025 07 15; 80(8):540-546.
    View in: PubMed
    Score: 0.043
  6. The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis. Semin Arthritis Rheum. 2020 10; 50(5):963-967.
    View in: PubMed
    Score: 0.030
  7. Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18. Arthritis Rheumatol. 2019 12; 71(12):2059-2067.
    View in: PubMed
    Score: 0.029
  8. Improved Cough and Cough-Specific Quality?of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II. Chest. 2017 Apr; 151(4):813-820.
    View in: PubMed
    Score: 0.024
  9. Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials. Arthritis Res Ther. 2015 Dec 23; 17:372.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.